Home StreetBriefs WeeklyNvidia moves from Hold to Buy as 11 of 15 analyses this week stayed at Hold

Nvidia moves from Hold to Buy as 11 of 15 analyses this week stayed at Hold

by Chaudhry Kramat Ali
0 comments
 
StreetBriefs
Weekly Digest
Week of November 09-15, 2026

Of the 15 ticker analyses published this week, 11 carried a Hold signal, 2 a Buy (Sandisk and TSMC) and 2 a Sell (Applied Digital and Relay Therapeutics). The pattern was familiar: strong growth was easy to find, and a price that fully reflects it was not. Several of the names covered, including AbbVie, Eli Lilly and Apple, were at or near two-year highs when the model scored them, and the Opportunity pillar is where most of them lost ground.

“
The four most dangerous words in investing are: ‘this time it’s different.’
– Sir John Templeton
By The Numbers
49
25.8% of watchlist
Buy Signals
116
61.1% of watchlist
Hold Signals
25
13.2% of watchlist
Sell Signals
Buy/Hold/Sell distribution across the StreetBriefs watchlist
Across 190 stocks on the StreetBriefs watchlist, snapshot as of 2026-10-20.
This Week’s Highlights

Sandisk: a Buy signal on a single-digit P/E

Sandisk was the week’s highest-scoring name, with a Buy signal, a P/E of 7.07 and trailing revenue growth of 377.9%. Quality scored 0.94, Growth 1.00 and Opportunity 0.83.

Why It Matters

A low multiple on a very fast-growing business is rare, but the article flags that cash flow lags profit. Figures like these can reverse quickly in a cyclical industry, so the cash-conversion question is worth watching.

Read Full Analysis →

SPCX: 161% growth against a 57x EV/Revenue multiple

Space Exploration Technologies reported trailing revenue growth of 161.4% and scored 0.80 on Growth, but only 0.09 on Opportunity. Its P/E is 604.83, and the model’s signal is Hold.

Why It Matters

This is the week’s clearest case of growth and valuation pulling in opposite directions. A multiple this high leaves little room for error if growth slows.

Read Full Analysis →

UnitedHealth: strong on valuation, weak on growth

UnitedHealth Group scored 0.73 on Opportunity, the highest of any Hold this week, with a P/E of 22.74. Trailing revenue growth was -0.4%, and the Growth score was 0.31.

Why It Matters

It is the mirror image of SPCX: a better valuation score with a stalled top line. Whether a lower valuation is compensation or a warning depends on whether revenue growth returns.

Read Full Analysis →

Signal Changes This Week: NVDA (Hold → Buy)

Nvidia (NVDA) moved from Hold to Buy in the model’s latest reading. Quality was unchanged at 93/100 and Growth edged from 90/100 to 91/100. The main shift was valuation: the P/E fell from 26.90 to 23.60, EV/EBITDA from 25.67 to 22.23, and the Opportunity score rose from 26/100 to 31/100. FCF yield moved from 0.8% to 0.9%, while revenue growth (105.9%), gross margin (74.7%) and operating margin (66.2%) were unchanged. In other words, the change came from the price becoming less demanding relative to earnings, not from a change in the business metrics. It is a model output for further research, not a recommendation to transact.

This Week’s Top 10
Company Signal Quality Growth Opp. P/E
Sandisk Corporation

SNDK
BUY 94 100 83 7.1
Taiwan Semiconductor Manufactur

TSM
BUY 97 90 44 26.9
Eli Lilly and Company

LLY
HOLD 81 83 11 46.1
AbbVie Inc.

ABBV
HOLD 73 56 35 50.7
Alphabet Inc.

GOOGL
HOLD 75 58 33 14.9
Advanced Micro Devices, Inc.

AMD
HOLD 79 69 8 123.9
TTM Technologies, Inc.

TTMI
HOLD 53 62 39 31.0
UnitedHealth Group Incorporated

UNH
HOLD 49 31 73 22.7
Space Exploration Technologies

SPCX
HOLD 61 80 9 604.8
Apple Inc.

AAPL
HOLD 83 49 18 38.9

Quality / Growth / Opportunity scored 0-100. Ranked by the model’s overall conviction (RecScore).

With so many strong businesses scoring low on valuation, it may be worth watching whether Opportunity scores improve as prices and earnings move. As always, the signals are a starting point for your own research.

Browse all analyses on the site

View All Articles →

Track these companies on the same model in Qubits Finance →
Want a stock we have not covered? Request an analysis →

StreetBriefs – get this digest in your inbox every Monday. Subscribe →

StreetBriefs is a financial publisher, not an investment adviser. Buy/Hold/Sell reflects our quantitative scoring model – a data-driven signal for further research, not personalized investment advice. This newsletter is for informational purposes only; always do your own due diligence and consult a licensed financial advisor before making investment decisions.

You may also like

0 0 votes
Article Rating
Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted